Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05567133 · ClinicalTrials.gov registry record
Risk Indicators of Sarcoidosis Evolution-Unified Protocol
A clinical trial of Sarcoidosis, Pulmonary, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT05567133 is a study of Sarcoidosis, Pulmonary that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants, above the 39-participant average among 3 other Sarcoidosis, Pulmonary trials with a reported enrollment target (413% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05567133, a study of Sarcoidosis, Pulmonary, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.
Conditions Studied
Study Locations (2)
Maryland
- University of Maryland - Baltimore
Texas
- UT Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2030-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05567133
The ClinicalTrials.gov registry entry for NCT05567133 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 39-participant average among 3 other Sarcoidosis, Pulmonary trials with a reported enrollment target (413% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sarcoidosis, Pulmonary appearing as the primary indexed condition, and to 0 interventions.
NCT05567133 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT05567133 about?
NCT05567133 is a clinical study titled "Risk Indicators of Sarcoidosis Evolution-Unified Protocol". The purpose of this study is to develop prediction models that can prognosticate patients with sarcoidosis using clinical data and blood markers that can be obtained during a clinic visit.
What is the current status of trial NCT05567133?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-01-10. Estimated completion is 2030-03-30.
What conditions does trial NCT05567133 study?
This clinical trial studies the following conditions: Sarcoidosis, Pulmonary.
Who is sponsoring clinical trial NCT05567133?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05567133 being conducted?
This trial has 2 study locations across Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoidosis, Pulmonary
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.